MSLead Chronicles
Episode 54: 2025 WRAPPED! A Look Back at Pharma's Moves and Shakes
37:55
2025 has been anything but boring. With exciting new drug/therapy approvals, big time merger & acquisition activity, and advances in rare and genetic diseases, Chad and Mary reflect on the past year and how it may impact the evolving role of medical affairs. You can't talk about 2026 without hitting on the gigantic pachyderm in the room that is AI. How will it enhance medical affairs and can it…